메뉴 건너뛰기
International Journal of Urology
Volumn 13, Issue 1, 2006, Pages 87-88
Discovery of a pituitary adenoma following treatment with a gonadotropin-releasing hormone agonist in a patient with prostate cancer
Author keywords

Hormonotherapy; Pituitary adenoma; Prostate cancer
Indexed keywords

ABARELIX; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LEUPRORELIN;
EID: 33645239353     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01237.x     Document Type: Article
Times cited : (13)
References (7)
  • 1
    • 0032323669 scopus 로고    scopus 로고
    • Gonadotropin releasing hormone analogue antiandrogen failure secondary to a pituitary adenoma
    • Ogan K Berger M Ball R Gonadotropin releasing hormone analogue antiandrogen failure secondary to a pituitary adenoma JUrol 1998 160 497 478
    • (1998) JUrol , vol.160 , pp. 497-478
    • Ogan, K.1    Berger, M.2    Ball, R.3
  • 2
    • 13344270378 scopus 로고    scopus 로고
    • Lack of effect of a gonadotropin-releasing hormone agonist in a patient with prostate cancer and a gonadotroph adenoma
    • Schuval BJ Kirschenbaum A Wolfe D Post KD Levine AC Lack of effect of a gonadotropin-releasing hormone agonist in a patient with prostate cancer and a gonadotroph adenoma JClinEndocrinolMetab 1996 81 864
    • (1996) JClinEndocrinolMetab , vol.81 , pp. 864
    • Schuval, B.J.1    Kirschenbaum, A.2    Wolfe, D.3    Post, K.D.4    Levine, A.C.5
  • 3
    • 0029062862 scopus 로고
    • Pituitary apoplexy caused by GnRH-agonist treatment revealing gonadotroph adenoma
    • Chanson P Schaison G Pituitary apoplexy caused by GnRH-agonist treatment revealing gonadotroph adenoma JClinEndocrinolMetab 1995 80 2268
    • (1995) JClinEndocrinolMetab , vol.80 , pp. 2268
    • Chanson, P.1    Schaison, G.2
  • 4
    • 4043156281 scopus 로고    scopus 로고
    • Hormone therapy in prostate cancer: LHRH antagonists versus LHRH analogues
    • discussion 283-4.
    • Weckermann D Harzmann R Hormone therapy in prostate cancer: LHRH antagonists versus LHRH analogues EurUrol 2004 46 279 83 discussion 283-4.
    • (2004) EurUrol , vol.46 , pp. 279-83
    • Weckermann, D.1    Harzmann, R.2
  • 5
    • 0035027393 scopus 로고    scopus 로고
    • Optimal starting time for flutamide to prevent disease flare in prostate cancer patients treated with a gonadotropin-releasing hormone agonist
    • Tsushima T Nasu Y Saika T et al. Optimal starting time for flutamide to prevent disease flare in prostate cancer patients treated with a gonadotropin-releasing hormone agonist UrolInt 2001 66 135 9
    • (2001) UrolInt , vol.66 , pp. 135-9
    • Tsushima, T.1    Nasu, Y.2    Saika, T.3
  • 6
    • 33645226533 scopus 로고    scopus 로고
    • GnRH analogues: The state of the art 2001
    • Siam O David CE GnRH analogues: the state of the art 2001 JUrol 2003 170 345 6
    • (2003) JUrol , vol.170 , pp. 345-6
    • Siam, O.1    David, C.E.2
  • 7
    • 0242664216 scopus 로고    scopus 로고
    • An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists
    • Koch M Steidle C Brosman S et al. An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists Urology 2003 62 877 82
    • (2003) Urology , vol.62 , pp. 877-82
    • Koch, M.1    Steidle, C.2    Brosman, S.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.